Traditionally, validation of prognostic factors is performed in cohorts grouping colon and rectal cancer together, rather than separately, for the sake of statistical power even though treatment approaches and tumor biology are markedly different. [5] [6] [7] It is necessary to ensure that such factors are valid for colon cancer as well as rectal cancer. An example of this discrepancy is extramural vascular invasion (EMVI) or vascular invasion beyond the muscularis propria. In large part, because of the potential finding of EMVI during preoperative magnetic resonance imaging in rectal cancer, 8, 9 a diagnostic modality that is not routinely performed in tumors of the colon. EMVI has been well scrutinized in rectal cancer, [10] [11] [12] but far less so in tumors of the colon. 13 Nonetheless, the College of American Pathologists recommend recording the status of vascular invasion during routine pathologic examination in both colon and rectal cancer patients 14 because of the unfavorable outcomes and increased risk of hepatic metastasis. 15 Current guidelines also incorporate vascular invasion as a histologic risk feature in colon cancer, for which adjuvant therapy could be considered. Besides lacking data on colon cancer specific outcomes, little is known about the importance of separating intramural and extramural venous invasion. Therefore, the aim of this study was to evaluate the impact of vascular invasion, both intramural and extramural, on long-term oncologic outcomes in stage II and III colon cancer patients without distant metastasis.
| METHODS

| Patients
All patients treated surgically for a primary colorectal carcinoma at
Massachusetts General Hospital between 2004 and 2015 (n = 2287)
were included in a prospectively maintained survival and outcomes database after institutional review board approval. Data on patients were gathered from patient visit records, the institutional research patient data repository, the social security death index, as well as patient records from our healthcare network.
Because of the significant differences in treatment approach, tumor biology, and the intent to specifically explore the impact of vascular invasion on colonic tumors, we exclusively focused on colon cancer and did not include patients with tumors of the rectum (n = 642). We excluded all patients with intramucosal tumors (n = 174) and patients with baseline metastatic disease (n = 246). 
| Pathologic examination
Standardized pathologic examination was performed by a team of dedicated gastrointestinal pathologists during the full length of our study. For the purpose of this study, tumors of the colon were defined as any tumor more than 15 centimeters from the anal verge.
Right-sided tumors included those located from the cecum to the hepatic flexure, transverse colon cancer included transverse tumors only, tumors located from the splenic flexure proximal to the sigmoid were defined as left-sided cancer, and (recto) sigmoid tumors were located from the sigmoid to the rectosigmoid. Tumor stage was assessed according to the seventh edition of the American Joint Committee on Cancer. 16 Tumor grading was categorized according to the classification designed by the World Health Organization. 17 The presence of vascular invasion was assessed on hematoxylin and eosin-stained (H&E) slides. Vessels with an unequivocal endothelial lining were considered lymphatic (small), whereas large vessels (venous) included all with a muscular wall. In suspicious cases, sections at multiple levels and elastic stains have been used to confirm venous invasion. Intramural vascular invasion (IMVI) was defined as the presence of large vessel invasion in the submucosal and/or muscular layer. Venous invasion beyond the muscularis propria was considered extramural vascular invasion ( Figure 1 ).
| Primary and secondary outcomes
Disease recurrence was our primary outcome. Recurrences were grouped by those that were locoregional, including all recurrences within the original tumor bed (contiguous to the original site of the tumor, peri-anastomotic, peritoneum, and retroperitoneum), and those which were distant (liver, lung, and other nonregional organs). 
| Statistical analysis
| Outcomes
| Subgroup analysis
In stage II disease, time to disease recurrence was comparable between patients with no invasion and IMVI only (5-year DFS, 85.5%
vs 93.3%, P = 0.332). OS and DSS were also comparable between these two groups (OS, P = 0.601; DSS, P = 0.208). Nonetheless, EMVI + patients demonstrated worse outcomes compared to those with no invasion (DFS, P = 0.002; OS, P = 0.001; DSS, P < 0.001; Figure 2 ).
The poor prognosis for EMVI+ tumors was emphasized in stage III disease. Time to disease recurrence, OS, as well DFS was all worse when extramural vascular invasion was present (P < 0.001), while no differences between the IMVI group and no invasion group were found. Interestingly, the estimated survival rates of stage III patients without vascular invasion or who were IMVI+ only were comparable with stage II EMVI+ patients (DFS: P = 0.281, DSS: P = 0.101). 
| Survival and multivariate analyses
| Current perspective
Extramural vascular invasion is already an important baseline characteristic in rectal cancer. 19, 20 As a prognostic factor, it is used to potentially predict high-risk disease or in some institutions to determine the need for preoperative chemoradiation. These tumors have an increased potential for vascular seeding as the tumor is aggressive enough to directly invade blood vessels, it makes sense that these patients are at higher risk of having occult disease.
Although the impact of EMVI is less well understood in colon cancer, vascular invasion should be taken into consideration as a high-risk feature in stage II disease, for which adjuvant therapy could be considered. Moreover, this study emphasized the difference between intramural and extramural vascular invasion, as only the latter was associated with poor outcomes.
Magnetic resonance imaging has made preoperative detection of EMVI in rectal cancer an important item of the baseline assessment. 21 This approach is not useful for tumors of the colon, as magnetic resonance imaging cannot account for the location and colonic peristalsis. Computed tomography is the only alternative but does not have sufficient resolution or tissue differentiation to identify vascular invasion reliably. Our study hypothesize that vascular invasion detected on histopathologic examination is a very important prognostic factor to predict recurrence and colon cancerspecific mortality proved to be true in this study comprising a large cohort of stage II and III colon cancer patients spanning over a decade. 
| Limitations and further research
